Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alén, M(arkku) |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Jartti, T(uomas) |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A(ndré) H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y(rjö) A(ntero) |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P(etri) |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J(ohanna) |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S(imo) |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T(aina) |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer | Puistola, U(lla) | 102 days | save |  |  |  |
| No Association Between Statin Use and the Prognosis of Endometrial Cancer in Women With Type 2 Diabetes | Puistola, U(lla) | 239 days | save | | | |
| Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes | Puistola, U(lla) | 252 days | save | | | |
| Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes | Puistola, U(lla) | 273 days | save | | | |
| Metformin and ovarian cancer: the evidence | Puistola, U(lla) | 273 days | save | | | |
| Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes | Puistola, U(lla) | 273 days | save | | | |
| Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study | Puistola, U(lla) | 273 days | save | | | |
| Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes | Puistola, U(lla) | 273 days | save | | | |
| Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes | Puistola, U(lla) | 273 days | save | | | |
| Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer | Puistola, U(lla) | 273 days | save | | | |
| Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism | Puistola, U(lla) | 273 days | save | | | |
| Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study | Puistola, U(lla) | 273 days | save | | | |
| Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes | Puistola, U(lla) | 273 days | save | | | |
| Immunohistochemical Analysis of the Spinal Cord Ischemia- Effect of Remote Ischemic Preconditioning in a Porcine Model | Puistola, U(lla) | 273 days | save | | | |
| The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study | Puistola, U(lla) | 273 days | save | | | |
| Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication | Puistola, U(lla) | 273 days | save | | | |
| Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes | Puistola, U(lla) | 273 days | save | | | |
| Pharmacological Preconditioning with Diazoxide in the Experimental Hypothermic Circulatory Arrest Model | Puistola, U(lla) | 273 days | save | | | |
| Exploring effects of remote ischemic preconditioning in a pig model of hypothermic circulatory arrest | Puistola, U(lla) | 273 days | save | | | |
| Exploring Spinal Cord Protection by Remote Ischemic Preconditioning: An Experimental Study | Puistola, U(lla) | 273 days | save | | | |
| Remote Ischemic Preconditioning Attenuates Oxidative Stress during Cardiopulmonary Bypass | Puistola, U(lla) | 273 days | save | | | |
| Remote Ischemic Preconditioning Reduces Cerebral Oxidative Stress Following Hypothermic Circulatory Arrest in a Porcine Model | Puistola, U(lla) | 273 days | save | | | |
| Cancer Stem Cell Properties as Factors Predictive of Chemoresistance in Neoadjuvantly-treated Patients with Ovarian Cancer | Puistola, U(lla) | 273 days | save | | | |
| Cancer in an elderly woman | Puistola, U(lla) | 273 days | save | | | |
| Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer | Puistola, U(lla) | 273 days | save | | | |
| The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B | Puistola, U(lla) | 273 days | save | | | |
| Impact of Epoetin-beta on anemia and health-related quality of life in cancer patients: a prospective observational study using the generic 15D instrument | Puistola, U(lla) | 273 days | save | | | |
| Treatment strategies in ovarian cancer | Puistola, U(lla) | 273 days | save | | | |
| L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation | Puistola, U(lla) | 273 days | save | | | |
| Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome | Puistola, U(lla) | 273 days | save | | | |
| Down-regulation of 8-hydroxydeoxyguanosine and peroxiredoxin II in the pathogenesis of endometriosis-associated ovarian cancer | Puistola, U(lla) | 273 days | save | | | |
| Update on current care guidelines: ovarian cancer | Puistola, U(lla) | 273 days | save | | | |
| Cancer diagnosed during pregnancy | Puistola, U(lla) | 273 days | save | | | |
| Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype | Puistola, U(lla) | 273 days | save | | | |
| Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility | Puistola, U(lla) | 273 days | save | | | |
| BMP-4 expression has prognostic significance in advanced serous ovarian carcinoma and is affected by cisplatin in OVCAR-3 cells | Puistola, U(lla) | 273 days | save | | | |
| Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis | Puistola, U(lla) | 273 days | save | | | |
| Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer | Puistola, U(lla) | 273 days | save | | | |
| Update on current care guidelines. Diagnosis, treatment and follow-up of cytological changes in the cervix, vagina and vulva | Puistola, U(lla) | 273 days | save | | | |
| Abdominal infection unresponsive from antibiotic therapy in middle-aged woman | Puistola, U(lla) | 273 days | save | | | |
| Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome | Puistola, U(lla) | 273 days | save | | | |
| Front-line bevacizumab in serous epithelial ovarian cancer: biomarker analysis of the FINAVAST trial | Puistola, U(lla) | 273 days | save | | | |
| Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis | Puistola, U(lla) | 273 days | save | | | |
| 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer | Puistola, U(lla) | 273 days | save | | | |
| Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours | Puistola, U(lla) | 273 days | save | | | |
| DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma | Puistola, U(lla) | 273 days | save | | | |
| The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer - a prospective nation-wide study in Finland | Puistola, U(lla) | 273 days | save | | | |
| FINHYST 2006--national prospective 1-year survey of 5,279 hysterectomies | Puistola, U(lla) | 273 days | save | | | |
| High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma | Puistola, U(lla) | 273 days | save | | | |
| Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy | Puistola, U(lla) | 273 days | save | | | |
| | 
report | next » | | |
|
